An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes (CAPTURE-IO)

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT03811288

NN2211-4446

U1111-1215-4005 (Other Identifier)

Details and patient eligibility

About

The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than prescribed to them by their doctor. Participants' participation will be one day/one visit at their doctor. The study will last for about 6 months in total.

Enrollment: 7,548 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent obtained before any study-related activities (study-related activities are any procedures related to recording of data according to protocol)
• Male or female, age more than or equal to 18 years at the time of signing informed consent (in Algeria more than or equal to 19 years; in Japan more than or equal to 20 years).
• Diagnosed with T2DM more than or equal to 180 days prior to the day of signing the informed consent

Exclusion criteria

• Previous participation in this study. Participation is defined as having given informed consent in this study
• Diagnosed with Type 1 diabetes
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• Patients with known congenital heart disease/malformation

Trial design

7,548 participants in 1 patient group

Participants with type 2 diabetes mellitus (T2DM)

Description:

T2DM patients being managed in both primary and specialist care in 10 selected countries.

Treatment:

Other: No treatment given